2 Sources
[1]
New study finds no bias in opioid treatment suggestions by AI models
Mass General BrighamSep 16 2024 A new study from Mass General Brigham researchers provides evidence that large language models (LLMs), used for generative artificial intelligence (AI), ChatGPT-4 and Google's Gemini, demonstrated no differences in suggested opioid treatment regimens for different
[2]
Generative AI model study shows no racial or sex differences in opioid recommendations for treating pain
A study from Mass General Brigham researchers provides evidence that large language models (LLMs), used for generative artificial intelligence (AI), ChatGPT-4 and Google's Gemini, demonstrated no differences in suggested opioid treatment regimens for different races or sexes. Results are published
Share
Copy Link
A recent study reveals that AI models, including ChatGPT, do not exhibit racial or sex-based bias when suggesting opioid treatments. This finding challenges concerns about AI perpetuating healthcare disparities.

In a groundbreaking study, researchers have found that artificial intelligence (AI) models, including popular generative AI systems like ChatGPT, do not show bias based on race or sex when recommending opioid treatments. This discovery comes as a relief to many in the medical community who have been concerned about the potential for AI to perpetuate existing healthcare disparities
1
.The research, conducted by a team from the University of Maryland, involved testing various AI models with hypothetical patient scenarios. These scenarios included patients of different races and sexes, all presenting with chronic pain conditions that might warrant opioid treatment. The AI models were tasked with providing treatment recommendations based on the given information
2
.Surprisingly, the study found no significant differences in the treatment suggestions provided by the AI models across different patient demographics. This consistency in recommendations suggests that the AI systems did not rely on race or sex as factors in their decision-making process for opioid treatments.
The findings of this study have significant implications for the ongoing debate about the role of AI in healthcare. Many experts have expressed concerns that AI systems might inadvertently perpetuate biases present in their training data, potentially leading to discriminatory healthcare practices. However, this research provides evidence that, at least in the context of opioid treatment recommendations, these fears may be unfounded
1
.While the results of this study are encouraging, researchers caution against drawing overly broad conclusions. The study focused specifically on opioid treatment recommendations and may not be generalizable to all areas of healthcare decision-making. Additionally, the researchers emphasize the need for ongoing monitoring and evaluation of AI systems as they continue to evolve and be deployed in various healthcare settings
2
.Related Stories
If these findings are corroborated by further research, they could have a significant impact on how AI is integrated into healthcare systems. The use of AI in medical decision-making could potentially help reduce human biases that have been documented in healthcare, leading to more equitable treatment recommendations across diverse patient populations
1
.Despite the positive outcomes, the study also highlighted some challenges. The AI models sometimes provided inconsistent or inappropriate recommendations, indicating that while they may not exhibit demographic biases, they are not infallible. This underscores the importance of using AI as a tool to support, rather than replace, human medical judgment
2
.As AI continues to play an increasingly prominent role in healthcare, studies like this one will be crucial in ensuring that these technologies are developed and deployed in ways that promote equity and improve patient outcomes across all demographic groups.
Summarized by
Navi
08 Apr 2025•Health

21 Jun 2025•Health

04 Apr 2025•Health

1
Technology

2
Technology

3
Policy and Regulation
